Bio-PRF

PreclinicalBiologic

UUniversity of Dublin, Trinity College

Bio-PRF is one of 3 biologic programs targeting Alveolar Osteitis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Alveolar OsteitisUnknown status

Alveolar OsteitisPreclinical

Unknown status

Competition

Competitive Landscape

3 competitors in Alveolar Osteitis

#DrugCompanyPhaseTrials

Alvogyl

WWatim Medical & Dental College

Phase 2

1 2

Platelet-Rich Fibrin (PRF)

FFederal University of São Paulo

Preclinical

1 3

Bio-PRF

UUniversity of Dublin, Trinity College

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Alveolar Osteitis1 trial

Treatment of Alveolar Osteitis: Traditional or Regenerative?

Unknown status·UUniversity of Dublin, Trinity College·N/A·NCT05615272·58 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Bio-PRF. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bio-PRF compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bio-PRF. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Dublin, Trinity College company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Dublin, Trinity College

Bio-PRF

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Alveolar Osteitis1 trial

References

Drug Info

Quick Facts

Related News